The New Economics of Radiation Oncology

摘要

Exacerbatmg the issue is the lack of a link between treatment and outcomes in some cases. A study published March 12 in Journal of the National Cancer Institute found no link between Medicare spending on advanced cancer and survival. "Most new advanced cancer therapies provide survival gains of weeks to months, and many are associated with high costs ... improving the value of medical spending for advanced cancer is increasingly recognized as a priority," wrote Gabriel A. Brooks, MD, of Dana-Farber Cancer Institute in Boston and colleagues.